Artificial insemination in livestock

01Overview and value chain#

Markers EC: EU zootechnical regulation (EU) 2016/1012 | OECD: Agricultural biotechnology | Regulator: USDA-APHIS (USA), EFSA (EU), NMPA (China)

Artificial insemination is the technology that decoupled livestock genetics from geography: semen collected from a genetically evaluated bull or boar is extended, frozen in straws, and inseminated thousands of kilometres away — so a sire’s genome becomes a logistics product. The economics that made it universal are the multiplier in the biology: one ejaculate splits into hundreds of insemination doses, and a single elite sire can serve tens of thousands of cows per year, which is why the genetic progress of national herds funnels through a few hundred sires. The industrial chain around the biology is where the field’s engineering lives — extenders that hold sperm viable across freeze-thaw, straws and packaging lines that fill hundreds of millions of doses, computer-assisted semen analysis that reads motility before a dose ships, and cryopreservation logistics that keep the cold chain unbroken from collection to insemination. The corpus’s ledger evidence shows the scale: a Canadian genetics cooperative reports 13.5 million semen doses produced in 2025 on revenue exceeding $180 million a year; a French equipment-and-consumables group runs seven production sites across five countries; and a German technology house’s systems stand behind hundreds of millions of doses produced annually by its customers.

Key directions of artificial insemination in livestock:

1. Genomic selection integrated with AI programs (Genomic Sires): young sires enter service on SNP-chip genomic evaluations before daughter proof exists — Semex’s genomic selection and sexed-semen programs pair SNP-chip evaluation with sex-sorted insemination products.
2. Semen packaging and cryopreservation equipment (Straw Lines): the filling, sealing and freezing lines that turn an ejaculate into shippable doses — IMV Technologies is a world leader in semen packaging and cryopreservation, its NIFA Technologies subsidiary in China part of the group since 2010 with origins in 1948.
3. Computer-assisted semen analysis (CASA Quality Gates): automated motility and morphology reading as the release test before doses ship, supplied worldwide by the same equipment layer.
4. Robotic dose manufacturing at herd scale (Automated Fill Lines): fully robotic semen packaging and freezing lines for cattle and swine — Minitube’s hosted Porcine TechDays 2026 drew roughly 80 in-person attendees around swine reproductive efficiency, alongside robotic lines running at production scale.

Sectoral value chain#

[genetic evaluation] ──> [sire station, collection] ──> [extension, CASA]
                                                              │
                                                  (dose quality release)
                                                              │
                                                              ▼
[insemination, conception] <── [cold-chain logistics] <── [fill, freeze, store]

Value chain levels#

Cross-cutting technologies of the sector:

• Sexed semen sorting (Flow-Cytometry Sexing): the upstream sibling technology that decides dose economics for dairy programs.
• Embryo production (OPU-IVF): in vitro embryo workflows that multiply elite females the way AI multiplied elite sires.
• Herd data platforms (Breeding Value Computing): the national databases that turn insemination records into the next generation’s evaluations.

02US#

The US is the largest single insemination market and the reference regulatory frame — USDA-APHIS governs semen exports — with the equipment layer present through European groups’ American sites.

USDA-APHIS frameworks, Midwest equipment manufacturing, dairy AI density#

• Minitube’s US manufacturing (Verona, Wisconsin): plastics and media production for the US market inside the German group’s three-site manufacturing footprint (Tiefenbach, Germany for headquarters, media production and logistics).
• USDA-APHIS as export gate: US semen exports certify under APHIS veterinary-biologicals frameworks — the reference regime international genetics flows are documented against.
• Dairy AI density as market depth: the practice rate of artificial insemination in US dairying is the demand floor that keeps equipment lines and dose production at industrial scale.

03CN#

China is the world’s largest pig-production market and a growing dairy market, reached less through domestic dose exports than through equipment and technology supply — IMV’s NIFA Technologies subsidiary has manufactured in China since the group acquired it in 2010.

NIFA manufacturing in China, swine AI scale, technology supply#

• NIFA Technologies (IMV group): originally founded in 1948 and part of IMV Technologies since 2010, the Chinese subsidiary anchors the group’s seven production sites across five countries (France, UK, Spain, Netherlands, China).
• Swine AI as the volume business: China’s swine herd makes artificial insemination the default breeding method at a scale no other market approaches; Minitube’s Porcine TechDays 2026 conference, drawing roughly 80 in-person attendees, tracks the technology transfer this market absorbs.
• Domestic genetics programs: national breeding programs build their own sire stations against NMPA-adjacent veterinary frameworks, with the equipment layer supplying the same CASA and freezing technology the export markets use.

04EU#

Europe is the technology home: the equipment layer’s original manufacturers, the zootechnical regulation that harmonizes breeding within the single market, and genetics cooperatives with global reach.

Zootechnical regulation, German and French equipment homes, European genetics houses#

• EU zootechnical framework (Regulation 2016/1012): the harmonized rules under which semen stations operate and breeding values circulate inside the single market — the certification substrate the sector’s European manufacturers build against.
• Minitube (Tiefenbach, Germany): ISO 9001:2015 and GMP compliance, over 400 employees worldwide, with headquarters, media production and logistics in Tiefenbach; its technology stands behind hundreds of millions of semen doses produced annually by customers.
• IMV Technologies (France): ISO 9001 and ISO 13485 compliance, FDA 510(k) clearances and CE marks on its equipment lines, six manufacturing facilities across five continents and over 650 employees globally as of 2025.

05Leading companies and research institutes#

06Tech stack and innovations#

The stack is biology wrapped in logistics: keep sperm alive through handling, measure what survives, and industrialize the package it ships in.

1. Semen extension and cryopreservation media (Extender Chemistry):
   • extenders buffer temperature shock and supply energy substrates so sperm survives freezing, thawing and the female tract.
   • case: dedicated media production at Minitube’s Tiefenbach site and IMV’s consumables lines, the volume backbone of dose economics.
2. Computer-assisted semen analysis (CASA Release Testing):
   • automated motility and morphology measurement turns dose quality into a number a laboratory can release against.
   • case: IMV’s CASA equipment line — a world-leader position in semen analysis and packaging supplying laboratories worldwide.
3. Robotic straw filling and freezing (Automated Dose Lines):
   • filling, sealing and freezing integrated into robotic lines that hold dose geometry and freeze curves constant at production speed.
   • case: Minitube’s fully robotic semen packaging and freezing lines for cattle and swine; Semex’s 13.5 million doses produced in 2025 through its Guelph operation and Génbank-Semex Hungary facility housing 230 young bulls.

07Value chains and production pipelines#

Industrial pipeline of a semen dose production campaign (licensed AI-station GMP regime)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Sire management        │ ───> │ 2. Collection             │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Fill and freeze        │ <─── │ 3. Extension and CASA     │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Cold-chain storage     │ ───> │ 6. Insemination service   │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Sire management

Elite sires are kept at licensed stations — Semex’s Génbank-Semex Hungary facility houses 230 young bulls — under feeding and health regimes that protect both semen quality and disease status.

Stage 2: Collection

Semen is collected by artificial vagina or electroejaculation under protocols that keep the collection traceable to the sire and the health program.

Stage 3: Extension and CASA

Raw ejaculates are extended within minutes, then read by computer-assisted semen analysis; motility and morphology numbers decide which ejaculates become doses.

Stage 4: Fill and freeze

Extended semen is filled into straws and frozen on programmed curves — robotic lines at Minitube-equipped stations hold geometry and freeze profile constant across hundreds of millions of doses a year.

Stage 5: Cold-chain storage

Frozen straws store in liquid nitrogen, with Boviteq-class embryology laboratories and distribution hubs keeping the chain unbroken between station and farm.

Stage 6: Insemination service

Doses thaw farm-side and are inseminated by technicians; conception records flow back into national databases and become the genetic evaluations the next sire catalogues sell on.